Rhone Ma Holdings Berhad (KLSE: RHONEMA)
Health Care · Pharmaceuticals · MY
RM0.67
-0.74% today · -6.3% 1Y
Rhone Ma Holdings Berhad (KLSE: RHONEMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $36.29M.
Over the last twelve months the share price has lost 6.3%, trading between 0.62 and 0.73.
Tweenvest scores Rhone Ma Holdings Berhad across four factors: quality 80/100, value 83/100, growth 50/100, dividend 76/100. Its strongest factor is value.
RHONEMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $36.29M
- Revenue (TTM)
- $56.04M
- P/E
- 12.11
- EPS
- 0.06
- Dividend yield
- 3.73%
- Beta (5Y)
- 0.15
- 52-week high
- RM0.73
- 52-week low
- RM0.62
- Avg volume (3M)
- —
- Shares outstanding
- 221.30M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Techno Drugs Ltd.DSE: TECHNODRUG | $38.05M | Tk35.50 | -13.83% |
| Planet 13 Holdings Inc.CNSX: PLTH | $37.60M | CA$0.16 | -15.79% |
| China Pharma Holdings, Inc.NYSEAM: CPHI | $37.45M | $0.83 | -4.86% |
| Impact BioMedical Inc.NYSEAM: IBO | $36.31M | $4.03 | -5.18% |
| Anxo Pharmaceutical Co., Ltd.TPEX: 6677 | $35.93M | NT$20.50 | +7.89% |
| Corline Biomedical ABOM: CLBIO | $35.81M | Skr13.70 | 0.00% |
| Nippon Chemiphar Co., Ltd.TSE: 4539 | $35.79M | ¥1,564.00 | -0.57% |
| Beit Jala Pharmaceutical CompanyPLSE: BJP | $35.75M | JD— | — |
Figures last refreshed Oct 11, 2026.